News & Updates

Aqueous shunts with extraocular reservoir lower IOP in adults with OAG

31 Jan 2024

Adults with open-angle glaucoma (OAG) may benefit from the implantation of aqueous shunts with extraocular reservoir, including valved or nonvalved devices, which can reduce intraocular pressure (IOP), as shown in a study.

Aqueous shunts with extraocular reservoir lower IOP in adults with OAG

31 Jan 2024

Myopic maculopathy progression occurs in 1 of 8 youths

31 Jan 2024

Among young people with high myopia, roughly 12 percent have myopic maculopathy progression over a period of 4 years, as shown in a study.

Myopic maculopathy progression occurs in 1 of 8 youths

31 Jan 2024

Cataract surgery in childhood poses increased risk of late-onset glaucoma

26 Jan 2024

Children who undergo cataract surgery appear to be at risk of having glaucoma later in life, according to a study.

Cataract surgery in childhood poses increased risk of late-onset glaucoma

26 Jan 2024

Cataract surgery yields long-term benefits for individuals with diabetes

14 Jan 2024

In people with diabetes, cataract surgery helps preserve both objective and subjective measures of visual function for up to 20 years, according to a study.

Cataract surgery yields long-term benefits for individuals with diabetes

14 Jan 2024

Optic neuropathy may induce vision loss in highly myopic eyes

11 Jan 2024

Optic neuropathy is the cause of vision impairment in 9.0 percent of eyes of highly myopic patients, according to a study. This rate is lower than the prevalence of myopic macular degeneration (MMD) as reason behind vision loss, which stands at 18.9 percent.

Optic neuropathy may induce vision loss in highly myopic eyes

11 Jan 2024

PDE5is do not induce ocular adverse events

10 Jan 2024

Use of phosphodiesterase 5 inhibitor (PDE5i) for erectile dysfunction (ED) or benign prostatic hyperplasia (BPD) does not seem to heighten the risk of ocular events in men, reveals a study.

PDE5is do not induce ocular adverse events

10 Jan 2024

Alzheimer's disease medications may protect against AMD

07 Jan 2024

Older adults with Alzheimer's disease who are receiving treatment with acetylcholinesterase inhibitors (AChEIs) appears to have a small reduction in the risk of age-related macular degeneration (AMD), as reported in a study.

Alzheimer's disease medications may protect against AMD

07 Jan 2024

Retinoblastoma treatment carries increased risk of neutropenia

30 Dec 2023

Neutropenia following intra-arterial chemotherapy occurs more frequently than previously reported among children with retinoblastoma, with topotecan possibly linked to a risk increase, according to a study.

Retinoblastoma treatment carries increased risk of neutropenia

30 Dec 2023

Brolucizumab noninferior to aflibercept for diabetic macular edema

29 Dec 2023

In the treatment of individuals with diabetic macular edema, brolucizumab yields similar visual outcomes as aflibercept, according to data from the phase III KINGFISHER trial.

Brolucizumab noninferior to aflibercept for diabetic macular edema

29 Dec 2023

Original New Drug Application Approvals by US FDA (01-15 December 2023)

18 Dec 2023

New drug applications approved by US FDA as of 01-15 December 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01-15 December 2023)

18 Dec 2023

News & Updates

Filter by Specialty:

Specialty:

Aqueous shunts with extraocular reservoir lower IOP in adults with OAG

Aqueous shunts with extraocular reservoir lower IOP in adults with OAG

Myopic maculopathy progression occurs in 1 of 8 youths

Myopic maculopathy progression occurs in 1 of 8 youths

Cataract surgery in childhood poses increased risk of late-onset glaucoma

Cataract surgery in childhood poses increased risk of late-onset glaucoma

Cataract surgery yields long-term benefits for individuals with diabetes

Cataract surgery yields long-term benefits for individuals with diabetes

Optic neuropathy may induce vision loss in highly myopic eyes

Optic neuropathy may induce vision loss in highly myopic eyes

PDE5is do not induce ocular adverse events

PDE5is do not induce ocular adverse events

Alzheimer's disease medications may protect against AMD

Alzheimer's disease medications may protect against AMD

Retinoblastoma treatment carries increased risk of neutropenia

Retinoblastoma treatment carries increased risk of neutropenia

Brolucizumab noninferior to aflibercept for diabetic macular edema

Brolucizumab noninferior to aflibercept for diabetic macular edema

Original New Drug Application Approvals by US FDA (01-15 December 2023)

Original New Drug Application Approvals by US FDA (01-15 December 2023)